nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Glutamine—TGM1—skin epidermis—melanoma	0.0189	0.0567	CbGeAlD
L-Glutamine—SLC7A8—optic choroid—melanoma	0.0138	0.0413	CbGeAlD
L-Glutamine—GLUL—optic choroid—melanoma	0.0107	0.0322	CbGeAlD
L-Glutamine—TGM2—endothelium—melanoma	0.0101	0.0301	CbGeAlD
L-Glutamine—TGM2—blood vessel—melanoma	0.00928	0.0278	CbGeAlD
L-Glutamine—QARS—hair follicle—melanoma	0.0078	0.0234	CbGeAlD
L-Glutamine—SLC7A8—skin epidermis—melanoma	0.0078	0.0234	CbGeAlD
L-Glutamine—TGM5—skin of body—melanoma	0.00725	0.0217	CbGeAlD
L-Glutamine—TGM2—neck—melanoma	0.00664	0.0199	CbGeAlD
L-Glutamine—TGM5—mammalian vulva—melanoma	0.00661	0.0198	CbGeAlD
L-Glutamine—SLC38A3—retina—melanoma	0.00653	0.0196	CbGeAlD
L-Glutamine—TGM1—skin of body—melanoma	0.00587	0.0176	CbGeAlD
L-Glutamine—Rigors—Vemurafenib—melanoma	0.00559	0.0299	CcSEcCtD
L-Glutamine—SLC7A8—hair follicle—melanoma	0.00557	0.0167	CbGeAlD
L-Glutamine—TGM3—skin of body—melanoma	0.0055	0.0165	CbGeAlD
L-Glutamine—TGM1—mammalian vulva—melanoma	0.00535	0.016	CbGeAlD
L-Glutamine—CCBL1—retina—melanoma	0.00525	0.0157	CbGeAlD
L-Glutamine—QARS—neck—melanoma	0.00524	0.0157	CbGeAlD
L-Glutamine—TGM3—mammalian vulva—melanoma	0.00501	0.015	CbGeAlD
L-Glutamine—TGM2—eye—melanoma	0.00494	0.0148	CbGeAlD
L-Glutamine—CTPS1—eye—melanoma	0.00465	0.0139	CbGeAlD
L-Glutamine—GFPT2—eye—melanoma	0.00457	0.0137	CbGeAlD
L-Glutamine—GLUL—hair follicle—melanoma	0.00433	0.013	CbGeAlD
L-Glutamine—TGM2—skin of body—melanoma	0.0043	0.0129	CbGeAlD
L-Glutamine—Nail disorder—Bleomycin—melanoma	0.00426	0.0228	CcSEcCtD
L-Glutamine—F13A1—eye—melanoma	0.0041	0.0123	CbGeAlD
L-Glutamine—F13A1—retina—melanoma	0.00406	0.0122	CbGeAlD
L-Glutamine—Haemorrhoids—Temozolomide—melanoma	0.00396	0.0212	CcSEcCtD
L-Glutamine—QARS—eye—melanoma	0.00389	0.0117	CbGeAlD
L-Glutamine—QARS—retina—melanoma	0.00386	0.0116	CbGeAlD
L-Glutamine—TGM1—head—melanoma	0.00383	0.0115	CbGeAlD
L-Glutamine—Glutathione—GLO1—melanoma	0.0038	0.284	CrCbGaD
L-Glutamine—L-Cysteine—MGMT—melanoma	0.00374	0.279	CrCbGaD
L-Glutamine—SLC7A8—neck—melanoma	0.00373	0.0112	CbGeAlD
L-Glutamine—CTPS1—mammalian vulva—melanoma	0.00369	0.0111	CbGeAlD
L-Glutamine—GMPS—mammalian vulva—melanoma	0.00369	0.0111	CbGeAlD
L-Glutamine—PFAS—mammalian vulva—melanoma	0.00362	0.0109	CbGeAlD
L-Glutamine—GFPT2—mammalian vulva—melanoma	0.00362	0.0109	CbGeAlD
L-Glutamine—CAD—eye—melanoma	0.00359	0.0108	CbGeAlD
L-Glutamine—TGM3—head—melanoma	0.00359	0.0107	CbGeAlD
L-Glutamine—CAD—retina—melanoma	0.00356	0.0107	CbGeAlD
L-Glutamine—QARS—skin of body—melanoma	0.00339	0.0101	CbGeAlD
L-Glutamine—PPAT—retina—melanoma	0.0033	0.00989	CbGeAlD
L-Glutamine—NADSYN1—head—melanoma	0.00328	0.00982	CbGeAlD
L-Glutamine—GLS2—head—melanoma	0.00328	0.00982	CbGeAlD
L-Glutamine—F13A1—mammalian vulva—melanoma	0.00325	0.00974	CbGeAlD
L-Glutamine—Aminolevulinic acid—SLC15A2—melanoma	0.00316	0.236	CrCbGaD
L-Glutamine—QARS—mammalian vulva—melanoma	0.00309	0.00925	CbGeAlD
L-Glutamine—SLC1A5—eye—melanoma	0.00309	0.00924	CbGeAlD
L-Glutamine—GATB—head—melanoma	0.00301	0.00901	CbGeAlD
L-Glutamine—CCBL1—head—melanoma	0.00301	0.00901	CbGeAlD
L-Glutamine—Injection site pain—Carmustine—melanoma	0.00295	0.0158	CcSEcCtD
L-Glutamine—GLUL—neck—melanoma	0.00291	0.0087	CbGeAlD
L-Glutamine—Rigors—Temozolomide—melanoma	0.00285	0.0153	CcSEcCtD
L-Glutamine—CAD—mammalian vulva—melanoma	0.00285	0.00854	CbGeAlD
L-Glutamine—GLS—head—melanoma	0.00283	0.00849	CbGeAlD
L-Glutamine—TGM2—head—melanoma	0.0028	0.0084	CbGeAlD
L-Glutamine—SLC1A5—skin of body—melanoma	0.00268	0.00804	CbGeAlD
L-Glutamine—TGM1—lymph node—melanoma	0.00268	0.00802	CbGeAlD
L-Glutamine—Breast pain—Temozolomide—melanoma	0.00267	0.0143	CcSEcCtD
L-Glutamine—ASNS—eye—melanoma	0.00265	0.00793	CbGeAlD
L-Glutamine—PPAT—mammalian vulva—melanoma	0.00264	0.00792	CbGeAlD
L-Glutamine—CTPS1—head—melanoma	0.00264	0.00791	CbGeAlD
L-Glutamine—GMPS—head—melanoma	0.00264	0.00791	CbGeAlD
L-Glutamine—Haemorrhoids—Docetaxel—melanoma	0.00264	0.0141	CcSEcCtD
L-Glutamine—PFAS—head—melanoma	0.00259	0.00776	CbGeAlD
L-Glutamine—Viral infection—Temozolomide—melanoma	0.00258	0.0138	CcSEcCtD
L-Glutamine—Neuropathy peripheral—Vemurafenib—melanoma	0.0025	0.0134	CcSEcCtD
L-Glutamine—SLC1A5—mammalian vulva—melanoma	0.00245	0.00733	CbGeAlD
L-Glutamine—SLC7A8—skin of body—melanoma	0.00242	0.00724	CbGeAlD
L-Glutamine—Injection site reaction—Carmustine—melanoma	0.0024	0.0128	CcSEcCtD
L-Glutamine—Nail disorder—Docetaxel—melanoma	0.00239	0.0128	CcSEcCtD
L-Glutamine—F13A1—head—melanoma	0.00233	0.00697	CbGeAlD
L-Glutamine—Candida infection—Carmustine—melanoma	0.0023	0.0123	CcSEcCtD
L-Glutamine—GLS2—lymph node—melanoma	0.0023	0.00688	CbGeAlD
L-Glutamine—NADSYN1—lymph node—melanoma	0.0023	0.00688	CbGeAlD
L-Glutamine—Sepsis—Dactinomycin—melanoma	0.00224	0.012	CcSEcCtD
L-Glutamine—Candida infection—Temozolomide—melanoma	0.00223	0.0119	CcSEcCtD
L-Glutamine—SLC16A10—neck—melanoma	0.00222	0.00664	CbGeAlD
L-Glutamine—QARS—head—melanoma	0.00221	0.00662	CbGeAlD
L-Glutamine—GLUL—eye—melanoma	0.00216	0.00647	CbGeAlD
L-Glutamine—GLUL—retina—melanoma	0.00214	0.00641	CbGeAlD
L-Glutamine—CCBL1—lymph node—melanoma	0.00211	0.00631	CbGeAlD
L-Glutamine—GATB—lymph node—melanoma	0.00211	0.00631	CbGeAlD
L-Glutamine—ASNS—mammalian vulva—melanoma	0.0021	0.00629	CbGeAlD
L-Glutamine—Sepsis—Carmustine—melanoma	0.00209	0.0112	CcSEcCtD
L-Glutamine—Angiopathy—Vemurafenib—melanoma	0.00208	0.0111	CcSEcCtD
L-Glutamine—Chills—Vemurafenib—melanoma	0.00206	0.011	CcSEcCtD
L-Glutamine—CAD—head—melanoma	0.00204	0.00611	CbGeAlD
L-Glutamine—Malnutrition—Vemurafenib—melanoma	0.00199	0.0107	CcSEcCtD
L-Glutamine—GLS—lymph node—melanoma	0.00198	0.00594	CbGeAlD
L-Glutamine—Back pain—Vemurafenib—melanoma	0.00193	0.0103	CcSEcCtD
L-Glutamine—Rigors—Docetaxel—melanoma	0.0019	0.0102	CcSEcCtD
L-Glutamine—PPAT—head—melanoma	0.00189	0.00566	CbGeAlD
L-Glutamine—GLUL—skin of body—melanoma	0.00188	0.00563	CbGeAlD
L-Glutamine—CTPS1—lymph node—melanoma	0.00185	0.00554	CbGeAlD
L-Glutamine—GMPS—lymph node—melanoma	0.00185	0.00554	CbGeAlD
L-Glutamine—GFPT2—lymph node—melanoma	0.00182	0.00544	CbGeAlD
L-Glutamine—PFAS—lymph node—melanoma	0.00182	0.00544	CbGeAlD
L-Glutamine—Thirst—Temozolomide—melanoma	0.00178	0.00952	CcSEcCtD
L-Glutamine—SLC1A5—head—melanoma	0.00175	0.00524	CbGeAlD
L-Glutamine—GLUL—mammalian vulva—melanoma	0.00172	0.00514	CbGeAlD
L-Glutamine—Myalgia—Vemurafenib—melanoma	0.0017	0.00909	CcSEcCtD
L-Glutamine—Arthralgia—Vemurafenib—melanoma	0.0017	0.00909	CcSEcCtD
L-Glutamine—F13A1—lymph node—melanoma	0.00163	0.00488	CbGeAlD
L-Glutamine—Infection—Vemurafenib—melanoma	0.00162	0.00866	CcSEcCtD
L-Glutamine—SLC7A8—head—melanoma	0.00158	0.00472	CbGeAlD
L-Glutamine—Dehydration—Temozolomide—melanoma	0.00157	0.00843	CcSEcCtD
L-Glutamine—QARS—lymph node—melanoma	0.00155	0.00464	CbGeAlD
L-Glutamine—Injection site reaction—Docetaxel—melanoma	0.00154	0.00825	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00148	0.00794	CcSEcCtD
L-Glutamine—Candida infection—Docetaxel—melanoma	0.00148	0.00793	CcSEcCtD
L-Glutamine—Abdominal distension—Temozolomide—melanoma	0.00147	0.00789	CcSEcCtD
L-Glutamine—L-Arginine—NOS2—melanoma	0.00145	0.108	CrCbGaD
L-Glutamine—CAD—lymph node—melanoma	0.00143	0.00428	CbGeAlD
L-Glutamine—Sweating increased—Temozolomide—melanoma	0.00142	0.00763	CcSEcCtD
L-Glutamine—Fatigue—Vemurafenib—melanoma	0.0014	0.00751	CcSEcCtD
L-Glutamine—Constipation—Vemurafenib—melanoma	0.00139	0.00745	CcSEcCtD
L-Glutamine—Depression—Carmustine—melanoma	0.00135	0.00721	CcSEcCtD
L-Glutamine—Sepsis—Docetaxel—melanoma	0.00135	0.00721	CcSEcCtD
L-Glutamine—PPAT—lymph node—melanoma	0.00132	0.00397	CbGeAlD
L-Glutamine—Neuropathy peripheral—Carmustine—melanoma	0.00132	0.00708	CcSEcCtD
L-Glutamine—SLC16A10—mammalian vulva—melanoma	0.00131	0.00392	CbGeAlD
L-Glutamine—Depression—Temozolomide—melanoma	0.0013	0.00696	CcSEcCtD
L-Glutamine—Body temperature increased—Vemurafenib—melanoma	0.00129	0.00689	CcSEcCtD
L-Glutamine—Pharyngitis—Dactinomycin—melanoma	0.00128	0.00688	CcSEcCtD
L-Glutamine—Neuropathy peripheral—Temozolomide—melanoma	0.00128	0.00685	CcSEcCtD
L-Glutamine—Chills—Bleomycin—melanoma	0.00125	0.00667	CcSEcCtD
L-Glutamine—L-Citrulline—NOS2—melanoma	0.00123	0.0921	CrCbGaD
L-Glutamine—GLUL—head—melanoma	0.00123	0.00367	CbGeAlD
L-Glutamine—SLC1A5—lymph node—melanoma	0.00123	0.00367	CbGeAlD
L-Glutamine—Hypersensitivity—Vemurafenib—melanoma	0.0012	0.00642	CcSEcCtD
L-Glutamine—Asthenia—Vemurafenib—melanoma	0.00117	0.00625	CcSEcCtD
L-Glutamine—Pharyngitis—Temozolomide—melanoma	0.00116	0.00622	CcSEcCtD
L-Glutamine—Chills—Dactinomycin—melanoma	0.00116	0.00622	CcSEcCtD
L-Glutamine—Urinary tract disorder—Temozolomide—melanoma	0.00116	0.00619	CcSEcCtD
L-Glutamine—Pruritus—Vemurafenib—melanoma	0.00115	0.00617	CcSEcCtD
L-Glutamine—Urethral disorder—Temozolomide—melanoma	0.00115	0.00615	CcSEcCtD
L-Glutamine—Ill-defined disorder—Bleomycin—melanoma	0.00112	0.006	CcSEcCtD
L-Glutamine—SLC7A8—lymph node—melanoma	0.0011	0.00331	CbGeAlD
L-Glutamine—Malaise—Bleomycin—melanoma	0.00109	0.00584	CcSEcCtD
L-Glutamine—Dizziness—Vemurafenib—melanoma	0.00108	0.00576	CcSEcCtD
L-Glutamine—Angiopathy—Temozolomide—melanoma	0.00106	0.00569	CcSEcCtD
L-Glutamine—Mental disorder—Carmustine—melanoma	0.00106	0.00568	CcSEcCtD
L-Glutamine—Malnutrition—Carmustine—melanoma	0.00105	0.00565	CcSEcCtD
L-Glutamine—ASNS—lymph node—melanoma	0.00105	0.00315	CbGeAlD
L-Glutamine—Chills—Temozolomide—melanoma	0.00105	0.00563	CcSEcCtD
L-Glutamine—Dehydration—Docetaxel—melanoma	0.00105	0.00561	CcSEcCtD
L-Glutamine—Ill-defined disorder—Dactinomycin—melanoma	0.00105	0.0056	CcSEcCtD
L-Glutamine—Vomiting—Vemurafenib—melanoma	0.00103	0.00554	CcSEcCtD
L-Glutamine—Chest pain—Bleomycin—melanoma	0.00103	0.00551	CcSEcCtD
L-Glutamine—Myalgia—Bleomycin—melanoma	0.00103	0.00551	CcSEcCtD
L-Glutamine—Rash—Vemurafenib—melanoma	0.00103	0.0055	CcSEcCtD
L-Glutamine—Mental disorder—Temozolomide—melanoma	0.00103	0.00549	CcSEcCtD
L-Glutamine—Dermatitis—Vemurafenib—melanoma	0.00103	0.00549	CcSEcCtD
L-Glutamine—Back pain—Carmustine—melanoma	0.00102	0.00546	CcSEcCtD
L-Glutamine—Headache—Vemurafenib—melanoma	0.00102	0.00546	CcSEcCtD
L-Glutamine—Malnutrition—Temozolomide—melanoma	0.00102	0.00546	CcSEcCtD
L-Glutamine—Discomfort—Bleomycin—melanoma	0.00102	0.00544	CcSEcCtD
L-Glutamine—Malaise—Dactinomycin—melanoma	0.00102	0.00544	CcSEcCtD
L-Glutamine—Oedema—Bleomycin—melanoma	0.000986	0.00528	CcSEcCtD
L-Glutamine—Back pain—Temozolomide—melanoma	0.000986	0.00528	CcSEcCtD
L-Glutamine—Infection—Bleomycin—melanoma	0.000979	0.00525	CcSEcCtD
L-Glutamine—Nausea—Vemurafenib—melanoma	0.000967	0.00518	CcSEcCtD
L-Glutamine—Myalgia—Dactinomycin—melanoma	0.000959	0.00514	CcSEcCtD
L-Glutamine—Discomfort—Dactinomycin—melanoma	0.000948	0.00508	CcSEcCtD
L-Glutamine—Ill-defined disorder—Temozolomide—melanoma	0.000945	0.00506	CcSEcCtD
L-Glutamine—Oedema—Dactinomycin—melanoma	0.000919	0.00493	CcSEcCtD
L-Glutamine—Malaise—Temozolomide—melanoma	0.000919	0.00492	CcSEcCtD
L-Glutamine—Infection—Dactinomycin—melanoma	0.000913	0.00489	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Bleomycin—melanoma	0.000898	0.00481	CcSEcCtD
L-Glutamine—Myalgia—Carmustine—melanoma	0.000898	0.00481	CcSEcCtD
L-Glutamine—Chest pain—Carmustine—melanoma	0.000898	0.00481	CcSEcCtD
L-Glutamine—Myalgia—Temozolomide—melanoma	0.000867	0.00465	CcSEcCtD
L-Glutamine—Arthralgia—Temozolomide—melanoma	0.000867	0.00465	CcSEcCtD
L-Glutamine—Oedema—Carmustine—melanoma	0.000861	0.00461	CcSEcCtD
L-Glutamine—GLUL—lymph node—melanoma	0.000859	0.00257	CbGeAlD
L-Glutamine—Discomfort—Temozolomide—melanoma	0.000857	0.00459	CcSEcCtD
L-Glutamine—Infection—Carmustine—melanoma	0.000855	0.00458	CcSEcCtD
L-Glutamine—Neuropathy peripheral—Docetaxel—melanoma	0.00085	0.00455	CcSEcCtD
L-Glutamine—Dry mouth—Temozolomide—melanoma	0.000848	0.00454	CcSEcCtD
L-Glutamine—Pain—Bleomycin—melanoma	0.000843	0.00452	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000838	0.00449	CcSEcCtD
L-Glutamine—Oedema—Temozolomide—melanoma	0.000832	0.00445	CcSEcCtD
L-Glutamine—Infection—Temozolomide—melanoma	0.000826	0.00443	CcSEcCtD
L-Glutamine—Feeling abnormal—Bleomycin—melanoma	0.000812	0.00435	CcSEcCtD
L-Glutamine—Hyperhidrosis—Temozolomide—melanoma	0.000804	0.00431	CcSEcCtD
L-Glutamine—Fatigue—Dactinomycin—melanoma	0.000793	0.00425	CcSEcCtD
L-Glutamine—Pain—Dactinomycin—melanoma	0.000786	0.00421	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Carmustine—melanoma	0.000784	0.0042	CcSEcCtD
L-Glutamine—Rhinitis—Docetaxel—melanoma	0.00078	0.00418	CcSEcCtD
L-Glutamine—Body temperature increased—Bleomycin—melanoma	0.000779	0.00417	CcSEcCtD
L-Glutamine—Insomnia—Carmustine—melanoma	0.000778	0.00417	CcSEcCtD
L-Glutamine—Pharyngitis—Docetaxel—melanoma	0.000773	0.00414	CcSEcCtD
L-Glutamine—Urinary tract disorder—Docetaxel—melanoma	0.000769	0.00412	CcSEcCtD
L-Glutamine—Urethral disorder—Docetaxel—melanoma	0.000763	0.00409	CcSEcCtD
L-Glutamine—Feeling abnormal—Dactinomycin—melanoma	0.000758	0.00406	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Temozolomide—melanoma	0.000758	0.00406	CcSEcCtD
L-Glutamine—Insomnia—Temozolomide—melanoma	0.000752	0.00403	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Dactinomycin—melanoma	0.000752	0.00403	CcSEcCtD
L-Glutamine—Constipation—Carmustine—melanoma	0.000736	0.00394	CcSEcCtD
L-Glutamine—Pain—Carmustine—melanoma	0.000736	0.00394	CcSEcCtD
L-Glutamine—Abdominal pain—Dactinomycin—melanoma	0.000727	0.00389	CcSEcCtD
L-Glutamine—Body temperature increased—Dactinomycin—melanoma	0.000727	0.00389	CcSEcCtD
L-Glutamine—Hypersensitivity—Bleomycin—melanoma	0.000726	0.00389	CcSEcCtD
L-Glutamine—Fatigue—Temozolomide—melanoma	0.000717	0.00384	CcSEcCtD
L-Glutamine—Constipation—Temozolomide—melanoma	0.000711	0.00381	CcSEcCtD
L-Glutamine—Pain—Temozolomide—melanoma	0.000711	0.00381	CcSEcCtD
L-Glutamine—Feeling abnormal—Carmustine—melanoma	0.000709	0.0038	CcSEcCtD
L-Glutamine—Asthenia—Bleomycin—melanoma	0.000707	0.00379	CcSEcCtD
L-Glutamine—Angiopathy—Docetaxel—melanoma	0.000706	0.00378	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Carmustine—melanoma	0.000704	0.00377	CcSEcCtD
L-Glutamine—Chills—Docetaxel—melanoma	0.000698	0.00374	CcSEcCtD
L-Glutamine—Pruritus—Bleomycin—melanoma	0.000697	0.00374	CcSEcCtD
L-Glutamine—Feeling abnormal—Temozolomide—melanoma	0.000685	0.00367	CcSEcCtD
L-Glutamine—Mental disorder—Docetaxel—melanoma	0.000682	0.00365	CcSEcCtD
L-Glutamine—Abdominal pain—Carmustine—melanoma	0.00068	0.00364	CcSEcCtD
L-Glutamine—Body temperature increased—Carmustine—melanoma	0.00068	0.00364	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Temozolomide—melanoma	0.00068	0.00364	CcSEcCtD
L-Glutamine—Malnutrition—Docetaxel—melanoma	0.000678	0.00363	CcSEcCtD
L-Glutamine—Hypersensitivity—Dactinomycin—melanoma	0.000677	0.00363	CcSEcCtD
L-Glutamine—Asthenia—Dactinomycin—melanoma	0.00066	0.00353	CcSEcCtD
L-Glutamine—Abdominal pain—Temozolomide—melanoma	0.000657	0.00352	CcSEcCtD
L-Glutamine—Body temperature increased—Temozolomide—melanoma	0.000657	0.00352	CcSEcCtD
L-Glutamine—Back pain—Docetaxel—melanoma	0.000655	0.00351	CcSEcCtD
L-Glutamine—SLC16A10—lymph node—melanoma	0.000655	0.00196	CbGeAlD
L-Glutamine—Hypersensitivity—Carmustine—melanoma	0.000634	0.0034	CcSEcCtD
L-Glutamine—Vomiting—Bleomycin—melanoma	0.000627	0.00336	CcSEcCtD
L-Glutamine—Rash—Bleomycin—melanoma	0.000622	0.00333	CcSEcCtD
L-Glutamine—Dermatitis—Bleomycin—melanoma	0.000621	0.00333	CcSEcCtD
L-Glutamine—Asthenia—Carmustine—melanoma	0.000617	0.00331	CcSEcCtD
L-Glutamine—Hypersensitivity—Temozolomide—melanoma	0.000613	0.00328	CcSEcCtD
L-Glutamine—Asthenia—Temozolomide—melanoma	0.000597	0.0032	CcSEcCtD
L-Glutamine—Pruritus—Temozolomide—melanoma	0.000588	0.00315	CcSEcCtD
L-Glutamine—Nausea—Bleomycin—melanoma	0.000586	0.00314	CcSEcCtD
L-Glutamine—Vomiting—Dactinomycin—melanoma	0.000585	0.00313	CcSEcCtD
L-Glutamine—Rash—Dactinomycin—melanoma	0.00058	0.00311	CcSEcCtD
L-Glutamine—Arthralgia—Docetaxel—melanoma	0.000577	0.00309	CcSEcCtD
L-Glutamine—Chest pain—Docetaxel—melanoma	0.000577	0.00309	CcSEcCtD
L-Glutamine—Myalgia—Docetaxel—melanoma	0.000577	0.00309	CcSEcCtD
L-Glutamine—Dizziness—Carmustine—melanoma	0.000569	0.00305	CcSEcCtD
L-Glutamine—Dry mouth—Docetaxel—melanoma	0.000564	0.00302	CcSEcCtD
L-Glutamine—Oedema—Docetaxel—melanoma	0.000553	0.00296	CcSEcCtD
L-Glutamine—Dizziness—Temozolomide—melanoma	0.00055	0.00295	CcSEcCtD
L-Glutamine—Infection—Docetaxel—melanoma	0.000549	0.00294	CcSEcCtD
L-Glutamine—Vomiting—Carmustine—melanoma	0.000547	0.00293	CcSEcCtD
L-Glutamine—Nausea—Dactinomycin—melanoma	0.000546	0.00293	CcSEcCtD
L-Glutamine—Rash—Carmustine—melanoma	0.000543	0.00291	CcSEcCtD
L-Glutamine—Dermatitis—Carmustine—melanoma	0.000542	0.0029	CcSEcCtD
L-Glutamine—Headache—Carmustine—melanoma	0.000539	0.00289	CcSEcCtD
L-Glutamine—Vomiting—Temozolomide—melanoma	0.000529	0.00283	CcSEcCtD
L-Glutamine—Rash—Temozolomide—melanoma	0.000524	0.00281	CcSEcCtD
L-Glutamine—Dermatitis—Temozolomide—melanoma	0.000524	0.00281	CcSEcCtD
L-Glutamine—Headache—Temozolomide—melanoma	0.000521	0.00279	CcSEcCtD
L-Glutamine—Nausea—Carmustine—melanoma	0.000511	0.00274	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Docetaxel—melanoma	0.000504	0.0027	CcSEcCtD
L-Glutamine—Insomnia—Docetaxel—melanoma	0.0005	0.00268	CcSEcCtD
L-Glutamine—Nausea—Temozolomide—melanoma	0.000494	0.00265	CcSEcCtD
L-Glutamine—Fatigue—Docetaxel—melanoma	0.000477	0.00255	CcSEcCtD
L-Glutamine—Pain—Docetaxel—melanoma	0.000473	0.00253	CcSEcCtD
L-Glutamine—Constipation—Docetaxel—melanoma	0.000473	0.00253	CcSEcCtD
L-Glutamine—Feeling abnormal—Docetaxel—melanoma	0.000456	0.00244	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Docetaxel—melanoma	0.000452	0.00242	CcSEcCtD
L-Glutamine—Body temperature increased—Docetaxel—melanoma	0.000437	0.00234	CcSEcCtD
L-Glutamine—Abdominal pain—Docetaxel—melanoma	0.000437	0.00234	CcSEcCtD
L-Glutamine—Hypersensitivity—Docetaxel—melanoma	0.000407	0.00218	CcSEcCtD
L-Glutamine—Asthenia—Docetaxel—melanoma	0.000397	0.00213	CcSEcCtD
L-Glutamine—Pruritus—Docetaxel—melanoma	0.000391	0.0021	CcSEcCtD
L-Glutamine—Dizziness—Docetaxel—melanoma	0.000366	0.00196	CcSEcCtD
L-Glutamine—Vomiting—Docetaxel—melanoma	0.000352	0.00188	CcSEcCtD
L-Glutamine—Rash—Docetaxel—melanoma	0.000349	0.00187	CcSEcCtD
L-Glutamine—Dermatitis—Docetaxel—melanoma	0.000348	0.00187	CcSEcCtD
L-Glutamine—Headache—Docetaxel—melanoma	0.000346	0.00186	CcSEcCtD
L-Glutamine—Nausea—Docetaxel—melanoma	0.000328	0.00176	CcSEcCtD
L-Glutamine—CCBL1—Disease—RAC1—melanoma	9.36e-05	0.000201	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—NOS2—melanoma	9.35e-05	0.000201	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—PIK3CG—melanoma	9.3e-05	0.0002	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—FN1—melanoma	9.3e-05	0.0002	CbGpPWpGaD
L-Glutamine—GFPT2—Metabolism of proteins—CTNNB1—melanoma	9.29e-05	0.000199	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—VEGFA—melanoma	9.26e-05	0.000199	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—NOTCH1—melanoma	9.26e-05	0.000199	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—GNA11—melanoma	9.23e-05	0.000198	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—ABCB1—melanoma	9.19e-05	0.000197	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—ABCB1—melanoma	9.19e-05	0.000197	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—ABCB1—melanoma	9.19e-05	0.000197	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—NOS2—melanoma	9.19e-05	0.000197	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—NRAS—melanoma	9.15e-05	0.000196	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—CD80—melanoma	9.07e-05	0.000195	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—KIT—melanoma	9.05e-05	0.000194	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—APC—melanoma	9.05e-05	0.000194	CbGpPWpGaD
L-Glutamine—SLC38A3—Transmembrane transport of small molecules—ALB—melanoma	9.05e-05	0.000194	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—FASN—melanoma	9.03e-05	0.000194	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—VCAN—melanoma	9.03e-05	0.000194	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—VCAN—melanoma	9.03e-05	0.000194	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—CYP1B1—melanoma	9e-05	0.000193	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—HIF1A—melanoma	8.98e-05	0.000193	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—PPARG—melanoma	8.97e-05	0.000193	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—EGF—melanoma	8.95e-05	0.000192	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—PIK3CG—melanoma	8.9e-05	0.000191	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—SLC5A5—melanoma	8.89e-05	0.000191	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—EGF—melanoma	8.79e-05	0.000189	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—MAPK3—melanoma	8.76e-05	0.000188	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—GNAQ—melanoma	8.58e-05	0.000184	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—CD44—melanoma	8.58e-05	0.000184	CbGpPWpGaD
L-Glutamine—GLUL—Transmission across Chemical Synapses—HRAS—melanoma	8.52e-05	0.000183	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—BRAF—melanoma	8.51e-05	0.000183	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—PRKCA—melanoma	8.46e-05	0.000182	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—PRKCA—melanoma	8.46e-05	0.000182	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—PRKCA—melanoma	8.46e-05	0.000182	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism of proteins—MMP1—melanoma	8.45e-05	0.000181	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—ERCC2—melanoma	8.39e-05	0.00018	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—ERCC2—melanoma	8.39e-05	0.00018	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—ERCC2—melanoma	8.39e-05	0.00018	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—MAPK1—melanoma	8.34e-05	0.000179	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—PIK3CG—melanoma	8.29e-05	0.000178	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—PIK3CG—melanoma	8.29e-05	0.000178	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—CYP1B1—melanoma	8.23e-05	0.000177	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—PIK3CD—melanoma	8.17e-05	0.000175	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—NOS2—melanoma	8.17e-05	0.000175	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—IGF1—melanoma	8.15e-05	0.000175	CbGpPWpGaD
L-Glutamine—GLUL—Neuronal System—MAPK1—melanoma	8.13e-05	0.000175	CbGpPWpGaD
L-Glutamine—SLC16A10—Transmembrane transport of small molecules—SLC5A5—melanoma	8.12e-05	0.000174	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—NOTCH1—melanoma	8.09e-05	0.000174	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—ALB—melanoma	8.07e-05	0.000173	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—MAP2K1—melanoma	8.01e-05	0.000172	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—PPARG—melanoma	8e-05	0.000172	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—PPARG—melanoma	8e-05	0.000172	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—PIK3CD—melanoma	7.96e-05	0.000171	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—CD80—melanoma	7.93e-05	0.00017	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—KIT—melanoma	7.91e-05	0.00017	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—APC—melanoma	7.91e-05	0.00017	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—KRAS—melanoma	7.88e-05	0.000169	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—PIK3CD—melanoma	7.82e-05	0.000168	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—EGF—melanoma	7.82e-05	0.000168	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—ALB—melanoma	7.72e-05	0.000166	CbGpPWpGaD
L-Glutamine—SLC16A10—SLC-mediated transmembrane transport—ALB—melanoma	7.63e-05	0.000164	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—FGF2—melanoma	7.62e-05	0.000163	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—CYP17A1—melanoma	7.62e-05	0.000163	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—CYP17A1—melanoma	7.62e-05	0.000163	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—PIK3CG—melanoma	7.58e-05	0.000163	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—BRAF—melanoma	7.44e-05	0.00016	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—ABCB1—melanoma	7.41e-05	0.000159	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—PPARG—melanoma	7.32e-05	0.000157	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—PIK3CD—melanoma	7.29e-05	0.000156	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—PIK3CD—melanoma	7.29e-05	0.000156	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—PIK3CA—melanoma	7.24e-05	0.000155	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—ALB—melanoma	7.19e-05	0.000154	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—ALB—melanoma	7.19e-05	0.000154	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—GNA11—melanoma	7.19e-05	0.000154	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—GNA11—melanoma	7.19e-05	0.000154	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—MDM2—melanoma	7.13e-05	0.000153	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—PIK3CB—melanoma	7.12e-05	0.000153	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—PTGS2—melanoma	7.06e-05	0.000151	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—FASN—melanoma	7.04e-05	0.000151	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—FASN—melanoma	7.04e-05	0.000151	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—ERBB2—melanoma	7.03e-05	0.000151	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—MAP2K1—melanoma	7e-05	0.00015	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—TP53—melanoma	7e-05	0.00015	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—PIK3CD—melanoma	6.95e-05	0.000149	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—PIK3CB—melanoma	6.94e-05	0.000149	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—SLC5A5—melanoma	6.92e-05	0.000149	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—SLC5A5—melanoma	6.92e-05	0.000149	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—CD4—melanoma	6.92e-05	0.000149	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—PTGS2—melanoma	6.87e-05	0.000147	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—PRKCA—melanoma	6.82e-05	0.000146	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—PIK3CB—melanoma	6.82e-05	0.000146	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—ABCB1—melanoma	6.78e-05	0.000145	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—ERCC2—melanoma	6.76e-05	0.000145	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism of proteins—IGF1—melanoma	6.76e-05	0.000145	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—HRAS—melanoma	6.69e-05	0.000144	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—GNAQ—melanoma	6.69e-05	0.000143	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—CD44—melanoma	6.69e-05	0.000143	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—CD44—melanoma	6.69e-05	0.000143	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—GNAQ—melanoma	6.69e-05	0.000143	CbGpPWpGaD
L-Glutamine—SLC7A8—Transmembrane transport of small molecules—ALB—melanoma	6.68e-05	0.000143	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—PIK3CD—melanoma	6.66e-05	0.000143	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—FGF2—melanoma	6.66e-05	0.000143	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—PIK3CG—melanoma	6.63e-05	0.000142	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—PIK3CG—melanoma	6.63e-05	0.000142	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—PIK3CG—melanoma	6.63e-05	0.000142	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—ALB—melanoma	6.58e-05	0.000141	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism of proteins—MMP2—melanoma	6.54e-05	0.00014	CbGpPWpGaD
L-Glutamine—GLUL—Neuronal System—HRAS—melanoma	6.53e-05	0.00014	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—CDKN1B—melanoma	6.51e-05	0.00014	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—CYP1B1—melanoma	6.41e-05	0.000138	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—CYP1B1—melanoma	6.41e-05	0.000138	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—PPARG—melanoma	6.39e-05	0.000137	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—PPARG—melanoma	6.39e-05	0.000137	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—PPARG—melanoma	6.39e-05	0.000137	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—PIK3CB—melanoma	6.35e-05	0.000136	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—PIK3CB—melanoma	6.35e-05	0.000136	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—PTGS2—melanoma	6.29e-05	0.000135	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—PTGS2—melanoma	6.29e-05	0.000135	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—IL2—melanoma	6.26e-05	0.000134	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—PRKCA—melanoma	6.24e-05	0.000134	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—MDM2—melanoma	6.23e-05	0.000134	CbGpPWpGaD
L-Glutamine—SLC16A10—Transmembrane transport of small molecules—ABCB1—melanoma	6.2e-05	0.000133	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—ERCC2—melanoma	6.18e-05	0.000133	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—PTEN—melanoma	6.16e-05	0.000132	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—CTNNB1—melanoma	6.15e-05	0.000132	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—ERBB2—melanoma	6.14e-05	0.000132	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—PIK3CB—melanoma	6.06e-05	0.00013	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—CD4—melanoma	6.05e-05	0.00013	CbGpPWpGaD
L-Glutamine—QARS—Gene Expression—MAPK3—melanoma	6.03e-05	0.000129	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—PTGS2—melanoma	6.01e-05	0.000129	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—CDKN1A—melanoma	6.01e-05	0.000129	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—PTEN—melanoma	5.99e-05	0.000129	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—AKT1—melanoma	5.91e-05	0.000127	CbGpPWpGaD
L-Glutamine—QARS—Gene Expression—MYC—melanoma	5.86e-05	0.000126	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—PIK3CD—melanoma	5.82e-05	0.000125	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—PIK3CD—melanoma	5.82e-05	0.000125	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—PIK3CD—melanoma	5.82e-05	0.000125	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—PIK3CB—melanoma	5.81e-05	0.000125	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—PTGS2—melanoma	5.75e-05	0.000123	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—ALB—melanoma	5.75e-05	0.000123	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—ALB—melanoma	5.75e-05	0.000123	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—ALB—melanoma	5.75e-05	0.000123	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—CDKN1B—melanoma	5.69e-05	0.000122	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—PTEN—melanoma	5.49e-05	0.000118	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—PTEN—melanoma	5.49e-05	0.000118	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism of proteins—CXCL8—melanoma	5.44e-05	0.000117	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—CTNNB1—melanoma	5.37e-05	0.000115	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—STAT3—melanoma	5.36e-05	0.000115	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—NRAS—melanoma	5.35e-05	0.000115	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—PIK3CG—melanoma	5.34e-05	0.000115	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—VEGFA—melanoma	5.32e-05	0.000114	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—ABCB1—melanoma	5.28e-05	0.000113	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—ABCB1—melanoma	5.28e-05	0.000113	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—NRAS—melanoma	5.26e-05	0.000113	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—CDKN1A—melanoma	5.25e-05	0.000113	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—PTEN—melanoma	5.24e-05	0.000112	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—PPARG—melanoma	5.15e-05	0.000111	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—MAPK3—melanoma	5.12e-05	0.00011	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—PIK3CB—melanoma	5.08e-05	0.000109	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—PIK3CB—melanoma	5.08e-05	0.000109	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—PIK3CB—melanoma	5.08e-05	0.000109	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—MAPK3—melanoma	5.03e-05	0.000108	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—PTGS2—melanoma	5.03e-05	0.000108	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—PTGS2—melanoma	5.03e-05	0.000108	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—PTGS2—melanoma	5.03e-05	0.000108	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—PTEN—melanoma	5.02e-05	0.000108	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism of proteins—CTNNB1—melanoma	5.02e-05	0.000108	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—MYC—melanoma	4.98e-05	0.000107	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—PIK3CG—melanoma	4.88e-05	0.000105	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—MAPK1—melanoma	4.87e-05	0.000105	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—EGFR—melanoma	4.87e-05	0.000105	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—PRKCA—melanoma	4.86e-05	0.000104	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—PRKCA—melanoma	4.86e-05	0.000104	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—ERCC2—melanoma	4.82e-05	0.000103	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—ERCC2—melanoma	4.82e-05	0.000103	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—MAPK1—melanoma	4.79e-05	0.000103	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—PPARG—melanoma	4.71e-05	0.000101	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—PIK3CD—melanoma	4.69e-05	0.000101	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—STAT3—melanoma	4.68e-05	0.000101	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—NRAS—melanoma	4.67e-05	0.0001	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—ALB—melanoma	4.63e-05	9.95e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—KRAS—melanoma	4.6e-05	9.88e-05	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—KRAS—melanoma	4.52e-05	9.71e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—MAPK3—melanoma	4.48e-05	9.6e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—PTEN—melanoma	4.39e-05	9.41e-05	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—PTEN—melanoma	4.39e-05	9.41e-05	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—PTEN—melanoma	4.39e-05	9.41e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—MYC—melanoma	4.35e-05	9.34e-05	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—PIK3CA—melanoma	4.34e-05	9.32e-05	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—PIK3CD—melanoma	4.29e-05	9.21e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—MAPK1—melanoma	4.26e-05	9.14e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—EGFR—melanoma	4.26e-05	9.14e-05	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—ALB—melanoma	4.24e-05	9.1e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—PIK3CA—melanoma	4.23e-05	9.07e-05	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—PIK3CA—melanoma	4.16e-05	8.92e-05	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—PIK3CB—melanoma	4.09e-05	8.78e-05	CbGpPWpGaD
L-Glutamine—QARS—Gene Expression—AKT1—melanoma	4.07e-05	8.73e-05	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—PTGS2—melanoma	4.05e-05	8.7e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—KRAS—melanoma	4.02e-05	8.63e-05	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—TP53—melanoma	4.02e-05	8.63e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—HRAS—melanoma	3.91e-05	8.39e-05	CbGpPWpGaD
L-Glutamine—SLC16A10—Transmembrane transport of small molecules—ALB—melanoma	3.88e-05	8.32e-05	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—PIK3CA—melanoma	3.87e-05	8.31e-05	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—PIK3CA—melanoma	3.87e-05	8.31e-05	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—HRAS—melanoma	3.85e-05	8.25e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—PIK3CG—melanoma	3.81e-05	8.17e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—PIK3CG—melanoma	3.81e-05	8.17e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—IL6—melanoma	3.74e-05	8.03e-05	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—PIK3CB—melanoma	3.74e-05	8.03e-05	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—PTGS2—melanoma	3.71e-05	7.96e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—PIK3CA—melanoma	3.7e-05	7.93e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—PPARG—melanoma	3.67e-05	7.88e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—PPARG—melanoma	3.67e-05	7.88e-05	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—AKT1—melanoma	3.55e-05	7.61e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—PIK3CA—melanoma	3.54e-05	7.6e-05	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—PTEN—melanoma	3.54e-05	7.59e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—AKT1—melanoma	3.45e-05	7.41e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—HRAS—melanoma	3.42e-05	7.34e-05	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—AKT1—melanoma	3.4e-05	7.29e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—PIK3CD—melanoma	3.35e-05	7.18e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—PIK3CD—melanoma	3.35e-05	7.18e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—ALB—melanoma	3.3e-05	7.09e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—ALB—melanoma	3.3e-05	7.09e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—IL6—melanoma	3.27e-05	7.02e-05	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—PTEN—melanoma	3.23e-05	6.94e-05	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—AKT1—melanoma	3.16e-05	6.79e-05	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—AKT1—melanoma	3.16e-05	6.79e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—PIK3CA—melanoma	3.09e-05	6.64e-05	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—PIK3CA—melanoma	3.09e-05	6.64e-05	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—PIK3CA—melanoma	3.09e-05	6.64e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—AKT1—melanoma	3.02e-05	6.48e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—PIK3CB—melanoma	2.92e-05	6.26e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—PIK3CB—melanoma	2.92e-05	6.26e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—AKT1—melanoma	2.89e-05	6.21e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—PTGS2—melanoma	2.89e-05	6.2e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—PTGS2—melanoma	2.89e-05	6.2e-05	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—AKT1—melanoma	2.53e-05	5.43e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—AKT1—melanoma	2.53e-05	5.43e-05	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—AKT1—melanoma	2.53e-05	5.43e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—PTEN—melanoma	2.52e-05	5.41e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—PTEN—melanoma	2.52e-05	5.41e-05	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—PIK3CA—melanoma	2.49e-05	5.35e-05	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—PIK3CA—melanoma	2.28e-05	4.9e-05	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—AKT1—melanoma	2.04e-05	4.37e-05	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—AKT1—melanoma	1.86e-05	4e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—PIK3CA—melanoma	1.78e-05	3.81e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—PIK3CA—melanoma	1.78e-05	3.81e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—AKT1—melanoma	1.45e-05	3.12e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—AKT1—melanoma	1.45e-05	3.12e-05	CbGpPWpGaD
